Bio-Dental Shareholder Meeting Set to Approve Merger with Zila Inc.SACRAMENTO, Calif.--(BUSINESS WIRE)--Dec. 3, 1996--Bio-Dental Technologies Corp. (NASDAQ/NMS:BDTC BDTC Base de Donnees Toponymiques du Canada (French: Database of Canada Toponymic) ) announced today that the Securities and Exchange Commission has declared effective its S-4 Registration Statement regarding the company's proposed merger with Zila Inc. This approval paves the way for the scheduling of a Bio-Dental shareholder meeting to approve the merger. Bio-Dental has set Dec. 30, 1996 as the date of its shareholder meeting to consider approval of the proposed merger. Shareholders of record as of Nov. 15, 1996 (the "Record Date") shall be entitled to vote at the meeting, although all Bio-Dental shareholders, past and present, are invited to attend. The meeting will be held near the company's headquarters in Rancho Cordova Rancho Cordova (răn`chō kôrdō`və), uninc. residential city (1990 pop. 48,731), Sacramento co., N Calif. A suburb of Sacramento, it experienced rapid growth in the late 20th cent. , Calif. Proxy materials Proxy Materials Documents regulated by the Securities & Exchange Commission in which a public company outlines its methods and procedures. These documents are used to inform shareholders and solicit votes for corporate decisions, such as the election of directors and other will be sent this week to all Bio-Dental shareholders as of the Record Date. The company is urging its shareholders to return their proxy ballots immediately so that the merger can be approved on schedule, and without further delay or cost. Curtis M. Rocca, president of Bio-Dental, said, "It feels good to have the regulatory hurdles behind us, and have matters back within our own control. All of us at Bio-Dental remain very excited about this merger with Zila, and believe that the combination of the two companies leaves us well-positioned for strong future growth, both internally and through strategic acquisitions." Bio-Dental Technologies Corp. manufactures, markets, and distributes dental supplies and proprietary, high-technology dental products to the $2-billion professional dental supply market in all 50 states and Canada. Zila Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ZILA) is an international marketer of oral healthcare products, including Zilactin(R), Zilactin-B, Zilactin-L, Zilactin-Lip and Quick Floss(TM), in markets worldwide. The company is the nation's only manufacturer of pharmaceutical grade toluidine blue toluidine blue an antiheparin compound, used also as a biological stain. Called also tolonium chloride. toluidine blue test a screening test for mucopolysaccharidosis, e.g. (the active ingredient in OraTest). The information set forth in this press release includes forward-looking statements and references to potential future developments. Such statements and references are based upon certain assumptions, including, but not limited to, the closing of the company's merger with Zila Inc., the approval of the merger by the company's shareholders, no unanticipated regulatory issues arising, FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval of Zila's OraTest cancer diagnostic, and the inherent marketability of OraTest through the company. CONTACT: Bio-Dental Technologies Corp., Sacramento Curtis M. Rocca III, 916/638-8147 (Pres./CEO) Terry E. Bane BANE. This word was formerly used to signify a malefactor. Bract. 1. 2, t. 8, c. 1. , 916/638-8147 (CFO See Chief Financial Officer. ) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion